PhRMA Scurries To Prepare For PDUFA: Currie Moves Up To Chief Lobbyist
Executive Summary
PhRMA's federal lobbying efforts heading into the Prescription Drug User Fee Act reauthorization deliberations will be led by one of the key staffers during the 1997 FDA Modernization Act debate.
You may also be interested in...
BIO Preparing For Human Subject Protection Provisions In FDA Bills
The Biotechnology Industry Organization is preparing for the inclusion of human subject protection provisions in FDA bills scheduled for action in 2002.
Amgen Working With Sen. Kennedy On Medicare Rx Benefit Bill
Amgen is working with the ranking Democrat on the Senate Health Committee, Sen. Kennedy (D-Mass.), to develop a Medicare prescription drug benefit bill.
PhRMA Seeking New Chief Lobbyist; Christy To Leave Association This Spring
PhRMA is seeking a new chief lobbyist to replace Senior VP-Federal Affairs James Christy, who is leaving the association in two months.